Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristen K Reynolds

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Clinics in Laboratory Medicine|December 9, 2008
Preface. Pharmacogenetics and its application to medicine by way of the clinical laboratoryKristen K Reynolds, Roland Valdes
Clinics in Laboratory Medicine|August 13, 2016
The Pharmacist's Perspective on Pharmacogenetics ImplementationFrederick Weitendorf, Kristen K Reynolds
Clinics in Laboratory Medicine|August 13, 2016
PrefaceKristen K Reynolds, Roland Valdes
Personalized Medicine|May 24, 2018
Current status of applied pharmacogenetics in clinical practiceKristen K Reynolds, Bonny L Bukaveckas
Clinics in Laboratory Medicine|December 9, 2008
The value of CYP2D6 and OPRM1 pharmacogenetic testing for opioid therapyKristen K Reynolds, Bronwyn Ramey-Hartung, Saeed A Jortani
Clinics in Laboratory Medicine|August 13, 2016
Clinical Utility and Economic Impact of CYP2D6 GenotypingKristen K Reynolds, Beth A McNally, Mark W Linder
Clinics in Laboratory Medicine|December 9, 2008
Pharmacogenetic testing in schizophrenia and posttraumatic stress disorderBronwyn Ramey-Hartung, Rifaat S El-Mallakh, Kristen K Reynolds
Personalized Medicine|May 17, 2018
Avoidable drug-gene conflicts and polypharmacy interactions in patients participating in a personalized medicine programKristen K Reynolds, Deanne L Pierce, Frederick Weitendorf, et al.
Personalized Medicine|May 26, 2018
Individualizing warfarin therapyKristen K Reynolds, Roland Valdes, Bronwyn R Hartung, et al.
Therapeutic Drug Monitoring|September 28, 2007
Identification of a synonymous polymorphism within the cytochrome P4502C9 gene that interferes with identification of the CYP2C9*2 alleleEdward P Womack, Kristen K Reynolds, Roland Valdes, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Clinics in Laboratory Medicine|December 9, 2008
Preface. Pharmacogenetics and its application to medicine by way of the clinical laboratoryKristen K Reynolds, Roland Valdes
Clinics in Laboratory Medicine|August 13, 2016
The Pharmacist's Perspective on Pharmacogenetics ImplementationFrederick Weitendorf, Kristen K Reynolds
Clinics in Laboratory Medicine|August 13, 2016
PrefaceKristen K Reynolds, Roland Valdes
Personalized Medicine|May 24, 2018
Current status of applied pharmacogenetics in clinical practiceKristen K Reynolds, Bonny L Bukaveckas
Clinics in Laboratory Medicine|December 9, 2008
The value of CYP2D6 and OPRM1 pharmacogenetic testing for opioid therapyKristen K Reynolds, Bronwyn Ramey-Hartung, Saeed A Jortani
Clinics in Laboratory Medicine|August 13, 2016
Clinical Utility and Economic Impact of CYP2D6 GenotypingKristen K Reynolds, Beth A McNally, Mark W Linder
Clinics in Laboratory Medicine|December 9, 2008
Pharmacogenetic testing in schizophrenia and posttraumatic stress disorderBronwyn Ramey-Hartung, Rifaat S El-Mallakh, Kristen K Reynolds
Personalized Medicine|May 17, 2018
Avoidable drug-gene conflicts and polypharmacy interactions in patients participating in a personalized medicine programKristen K Reynolds, Deanne L Pierce, Frederick Weitendorf, et al.
Personalized Medicine|May 26, 2018
Individualizing warfarin therapyKristen K Reynolds, Roland Valdes, Bronwyn R Hartung, et al.
Therapeutic Drug Monitoring|September 28, 2007
Identification of a synonymous polymorphism within the cytochrome P4502C9 gene that interferes with identification of the CYP2C9*2 alleleEdward P Womack, Kristen K Reynolds, Roland Valdes, et al.
Pageof 2